Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Third Line”

284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 284 results

Testing effectiveness (Phase 2)UnknownNCT05342389
What this trial is testing

Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 68
Testing effectiveness (Phase 2)Study completedNCT04953962
What this trial is testing

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
CanBas Co. Ltd. 36
Not applicableActive Not RecruitingNCT06092879
What this trial is testing

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 201
Testing effectiveness (Phase 2)UnknownNCT05278351
What this trial is testing

Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC

Who this might be right for
Colorectal Neoplasms Malignant
Shanghai Zhongshan Hospital 87
Testing effectiveness (Phase 2)Study completedNCT02794077
What this trial is testing

Cyclophosphamide for Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Undifferentiated CarcinomaStage IV Nasopharyngeal Undifferentiated Carcinoma
The University of Hong Kong 56
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Testing effectiveness (Phase 2)Study completedNCT04444622
What this trial is testing

Immunotherapy for Third Line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Mirror Biologics, Inc. 29
Testing effectiveness (Phase 2)UnknownNCT04709731
What this trial is testing

Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia (CML)
Associazione Italiana Pazienti Leucemia Mieloide Cronica 50
Not applicableLooking for participantsNCT05598528
What this trial is testing

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Who this might be right for
Lung Cancer, Non-small CellEGFR Gene MutationEGFR-TKI Resistant Mutation+2 more
Second Xiangya Hospital of Central South University 210
Testing effectiveness (Phase 2)UnknownNCT05266820
What this trial is testing

Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital 120
Not applicableStudy completedNCT05117918
What this trial is testing

Overactive Bladder Telemedicine Non-inferiority Trial

Who this might be right for
Overactive Bladder
University of California, Los Angeles 177
Not applicableStudy completedNCT02547025
What this trial is testing

Personalized Treatment for Refractory H Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Kaohsiung Veterans General Hospital. 126
Large-scale testing (Phase 3)Looking for participantsNCT06911502
What this trial is testing

Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Who this might be right for
Follicular Lymphoma
Celgene 400
Large-scale testing (Phase 3)Looking for participantsNCT07270991
What this trial is testing

Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

Who this might be right for
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive 324
Not applicableUnknownNCT05764941
What this trial is testing

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02004262
What this trial is testing

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Who this might be right for
2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer
Aduro Biotech, Inc. 303
Testing effectiveness (Phase 2)Study completedNCT00792363
What this trial is testing

Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 32
Not applicableLooking for participantsNCT06678919
What this trial is testing

AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Arbeitsgemeinschaft medikamentoese Tumortherapie 500
Testing effectiveness (Phase 2)Study completedNCT00105092
What this trial is testing

Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 50
Large-scale testing (Phase 3)Study completedNCT03556956
What this trial is testing

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
AB Science 219
Load More Results